Jim Siderov

1.3k total citations
37 papers, 372 citations indexed

About

Jim Siderov is a scholar working on Oncology, Occupational Therapy and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jim Siderov has authored 37 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Occupational Therapy and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jim Siderov's work include Safe Handling of Antineoplastic Drugs (11 papers), Pharmaceutical studies and practices (10 papers) and Pharmaceutical Practices and Patient Outcomes (9 papers). Jim Siderov is often cited by papers focused on Safe Handling of Antineoplastic Drugs (11 papers), Pharmaceutical studies and practices (10 papers) and Pharmaceutical Practices and Patient Outcomes (9 papers). Jim Siderov collaborates with scholars based in Australia, United States and United Kingdom. Jim Siderov's co-authors include Sue Kirsa, Richard de Boer, Jayesh Desai, John Zalcberg, John Simes, David C. M. Kong, Jennifer Marriott, Bogda Koczwara, Alexandre Chan and Shelley Rushton and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Jim Siderov

34 papers receiving 362 citations

Peers

Jim Siderov
Carole Chambers Canada
Marianna Aita Italy
Benyam Muluneh United States
Jose Luís Poveda Andrés Spain
Jean‐François Tournamille France
Alison Duffy United States
Laura Winter United States
Olivier Colomban France
Eva González-Haba Spain
E De Cock United Kingdom
Carole Chambers Canada
Jim Siderov
Citations per year, relative to Jim Siderov Jim Siderov (= 1×) peers Carole Chambers

Countries citing papers authored by Jim Siderov

Since Specialization
Citations

This map shows the geographic impact of Jim Siderov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Siderov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Siderov more than expected).

Fields of papers citing papers by Jim Siderov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Siderov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Siderov. The network helps show where Jim Siderov may publish in the future.

Co-authorship network of co-authors of Jim Siderov

This figure shows the co-authorship network connecting the top 25 collaborators of Jim Siderov. A scholar is included among the top collaborators of Jim Siderov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Siderov. Jim Siderov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Neill, Niamh, David W. Johnson, Aisling Kelly, et al.. (2025). A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function. EClinicalMedicine. 82. 103101–103101.
2.
Green, S., et al.. (2025). Pre- and post-treatment care for actinic keratoses: An Australian and New Zealand perspective. Australian Journal of General Practice. 54(8). 541–546.
3.
Siderov, Jim, et al.. (2023). Clinical Oncology Society of Australia Position Statement: 2022 update to the safe handling of monoclonal antibodies in healthcare settings. Asia-Pacific Journal of Clinical Oncology. 19(6). 723–730. 4 indexed citations
4.
Tong, Erica, et al.. (2023). Implementation of Partnered Pharmacist Medication Charting in haematology and oncology inpatients. Journal of Oncology Pharmacy Practice. 30(4). 636–641. 4 indexed citations
5.
Stojanova, Jana, et al.. (2022). Therapeutic drug monitoring in oncology - What’s out there: A bibliometric evaluation on the topic. Frontiers in Oncology. 12. 959741–959741. 5 indexed citations
6.
Tam, Constantine S., Jim Siderov, John F. Seymour, et al.. (2019). High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia – lessons for immunopathogenesis and prescribing. Leukemia & lymphoma. 60(14). 3455–3460. 5 indexed citations
7.
Koczwara, Bogda, Jim Siderov, Ben C. Stevenson, et al.. (2010). The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy. Asia-Pacific Journal of Clinical Oncology. 6(3). 220–237. 35 indexed citations
8.
Siderov, Jim & John M. Duggan. (2009). Arsenic trioxide associated toothache. Journal of Oncology Pharmacy Practice. 16(2). 127–128. 4 indexed citations
9.
Marriott, Jennifer, et al.. (2008). Implementation of a community liaison pharmacy service: a randomised controlled trial. International Journal of Pharmacy Practice. 16(3). 127–135. 23 indexed citations
10.
Siderov, Jim. (2005). Your questions to the PBAC: Aprepitant - recommendations for PBS listing. Australian Prescriber. 28(5). 119–119. 2 indexed citations
11.
Dooley, Michael, et al.. (2003). CORRESPONDENCE. Journal of Clinical Oncology. 21(10). 2045–2045. 5 indexed citations
12.
Siderov, Jim, et al.. (2003). Workload Statistics in Cytotoxic Preparation—Is a One‐for‐One Approach Enough?. Journal of Pharmacy Practice and Research. 33(1). 68–69. 1 indexed citations
13.
Siderov, Jim, et al.. (2002). Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide. British Journal of Cancer. 86(1). 12–13. 44 indexed citations
14.
15.
16.
17.
Siderov, Jim. (1999). BCOP: a New Regimen for the Oncology Pharmacist. The Australian Journal of Hospital Pharmacy. 29(6). 338–341. 3 indexed citations
18.
19.
Siderov, Jim & Paul Mitchell. (1998). Cancer Chemotherapy in the Elderly. The Australian Journal of Hospital Pharmacy. 28(2). 124–129. 4 indexed citations
20.
Siderov, Jim, et al.. (1995). Quality of pharmacokinetic research in oncology. British Journal of Cancer. 72(3). 792–794. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carole Chambers Breakdown of academic impact, for papers by Marianna Aita Breakdown of academic impact, for papers by Benyam Muluneh Breakdown of academic impact, for papers by Jose Luís Poveda Andrés Breakdown of academic impact, for papers by Jean‐François Tournamille Breakdown of academic impact, for papers by Alison Duffy Breakdown of academic impact, for papers by Laura Winter Breakdown of academic impact, for papers by Olivier Colomban Breakdown of academic impact, for papers by Eva González-Haba Breakdown of academic impact, for papers by E De Cock
Rankless by CCL
2026